landiolol has been researched along with Atrial Flutter in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domanovits, H; Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Stix, G; Trebs, M; Unger, M; Wolzt, M | 1 |
| Fujimoto, Y; Hayashi, H; Hayashi, M; Ito-Hagiwara, K; Iwasaki, YK; Maru, E; Oka, E; Shimizu, W; Yamamoto, T; Yodogawa, K | 1 |
| Imamura, T; Nitta, D | 1 |
| Iwasaki, YK; Oka, E; Shimizu, W | 1 |
| Mizutani, H; Nakasu, Y; Sumitani, K; Yamashita, T | 1 |
| Momomura, S | 1 |
| Aiba, T; Atarashi, H; Daimon, T; Fujino, K; Hori, M; Ikeda, T; Imai, Y; Inoue, H; Kinugawa, K; Kitakaze, M; Nagai, R; Nagano, T; Okamura, T; Sakamoto, A; Seino, Y; Shimizu, W; Yamashita, T | 2 |
| Matsushita, M; Saitoh, T; Yamashita, T | 1 |
| Arashi, T; Haruyama, N; Mae, T; Takata, J | 1 |
| Horigome, H; Iwamoto, M; Miura, M; Miyazaki, A; Nagano, T; Ohashi, N; Ono, H; Sagawa, K; Sakaguchi, H; Sumitomo, N; Suzuki, T; Takahashi, K; Takamuro, M; Takigiku, K; Tokunaga, C; Ueda, H; Ushinohama, H; Yoshimoto, J | 1 |
| Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K | 1 |
| Ibe, T; Kamiyoshihara, M; Kawashima, O; Nagashima, T; Nakano, T; Shimizu, K; Takeyoshi, I | 1 |
4 trial(s) available for landiolol and Atrial Flutter
| Article | Year |
|---|---|
Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Humans; Middle Aged; Morpholines; Pilot Projects; Prospective Studies; Urea | 2019 |
Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Tachycardia; Urea; Ventricular Dysfunction, Left | 2013 |
Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Digoxin; Drug Monitoring; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Severity of Illness Index; Stroke Volume; Treatment Outcome; Urea; Ventricular Dysfunction, Left | 2014 |
Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Female; Heart Failure; Heart Rate; Humans; Infant; Infusions, Intravenous; Male; Morpholines; Research Design; Tachycardia; Urea | 2017 |
9 other study(ies) available for landiolol and Atrial Flutter
| Article | Year |
|---|---|
Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Tachycardia; Urea; Ventricular Dysfunction, Left | 2019 |
What Determines the Response to Landiolol?
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Morpholines; Tachycardia; Urea; Ventricular Dysfunction, Left | 2019 |
What Determines the Response to Landiolol? - Reply.
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Morpholines; Tachycardia; Urea; Ventricular Dysfunction, Left | 2019 |
A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Japan; Male; Middle Aged; Morpholines; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Urea | 2019 |
Acute rate control in atrial fibrillation with left ventricular dysfunction.
Topics: Adrenergic beta-1 Receptor Antagonists; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Female; Heart Rate; Humans; Male; Morpholines; Tachycardia; Urea; Ventricular Dysfunction, Left | 2013 |
Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aged; Atrial Fibrillation; Atrial Flutter; Female; Heart Failure; Humans; Japan; Male; Morpholines; Prospective Studies; Research Design; Urea | 2015 |
Alteration of fatal 1:1 conducted atrial flutter to less conducted ratio by landiolol infusion.
Topics: Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Humans; Male; Morpholines; Urea; Ventricular Dysfunction, Left | 2016 |
Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atrial Premature Complexes; Blood Pressure; Drug Administration Schedule; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Care; Surgical Procedures, Operative; Tachycardia, Sinus; Time Factors; Treatment Outcome; Urea | 2009 |
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Morpholines; Retrospective Studies; Secondary Prevention; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2012 |